Setterwalls has advised OssDsign in connection with directed share issue of approximately SEK 150 million

Setterwalls has advised OssDsign AB in connection with a directed share issue of approximately SEK 150 million to Swedish and international institutional investors.

OssDsign is a developer and global provider of next generation bone replacement products. The company develops and markets products that support the body’s own healing capabilities and thereby improve the clinical outcome in a wide range of orthopedic areas with high medical needs. The company’s shares are listed on Nasdaq First North Growth Market.